Fig. 4From: Pan-cancer analysis of the prognostic and immunological role of SNX29: a potential target for survival and immunotherapyRelationship between SNX29 gene expression and clinical stage. A BLCA, B KIRC, C LUAD, D TGCT, E THCABack to article page